World Health Organ Tech Rep Ser. 2014(980):1-489, back cover.
This report presents the recommendations of a WHO Expert Committee commissioned to coordinate activities leading to the adoption of international recommendations for the production and control of vaccines and other biologicals, and the establishment of international biological reference materials. Following a brief introduction, the report summarizes a number of general issues brought to the attention of the Committee. The next part of the report, of particular relevance to manufacturers and national regulatory authorities, outlines the discussions held on the development of revised WHO Recommendations and Guidelines for a number of vaccines, blood products and related substances. Specific discussion areas included the development of WHO guidance on the quality, safety and efficacy of poliomyelitis vaccines; recombinant malaria vaccines; diphtheria vaccines; tetanus vaccines; combined vaccines based on diphtheria and tetanus vaccines; and Japanese encephalitis vaccines. Subsequent sections of the report then provide information on the current status and proposed development of international reference materials in the areas of vaccines and related substances; blood products and related substances; in vitro diagnostic device reagents; biotherapeutics other than blood products; and antibiotics. A series of annexes are then presented which include an updated list of WHO Recommendations, Guidelines and other documents on biological substances used in medicine (Annex 1), followed by a series of WHO Recommendations and Guidelines adopted on the advice of the Committee (Annexes 2-7). All additions made during the meeting to the list of International Standards and Reference Reagents for biological substances maintained by WHO are then summarized in Annex 8, and are also available at: http://www. who.int/biologicals.
本报告介绍了世界卫生组织一个专家委员会的建议。该委员会受委托协调各项活动,以推动通过关于疫苗和其他生物制品生产与控制的国际建议,并建立国际生物参考物质。在简短介绍之后,报告总结了引起委员会关注的一些一般性问题。报告的下一部分对制造商和国家监管当局尤为重要,概述了就修订世界卫生组织针对多种疫苗、血液制品及相关物质的建议和指南所进行的讨论。具体讨论领域包括世界卫生组织关于脊髓灰质炎疫苗质量、安全性和有效性的指南制定;重组疟疾疫苗;白喉疫苗;破伤风疫苗;基于白喉和破伤风疫苗的联合疫苗;以及日本脑炎疫苗。报告随后的章节提供了疫苗及相关物质、血液制品及相关物质、体外诊断设备试剂、非血液制品生物治疗药物和抗生素等领域国际参考物质的现状及拟议发展情况的信息。接着列出了一系列附件,其中包括世界卫生组织关于医学中使用的生物物质的建议、指南和其他文件的最新清单(附件1),随后是根据委员会建议通过的一系列世界卫生组织建议和指南(附件2 - 7)。会议期间对世界卫生组织维护的生物物质国际标准和参考试剂清单所做的所有增补内容在附件8中进行了总结,也可在以下网址查阅:http://www.who.int/biologicals 。